Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1978 Jun;5(6):523-5.
doi: 10.1111/j.1365-2125.1978.tb01667.x.

Bronchodilator Effect of delta1-tetrahydrocannabinol

Free PMC article
Clinical Trial

Bronchodilator Effect of delta1-tetrahydrocannabinol

J P Hartley et al. Br J Clin Pharmacol. .
Free PMC article

Abstract

1 delta1-trans-tetrahydrocannabinol, (delta1-THC) produces bronchodilatation in asthmatic patients. 2 Administered in 62 microliter metered volumes containing 50--200 microgram by inhalation from an aerosol device to patients judged to be in a steady state, it increased peak expiratory flow rate (PEFR) and forced expiratory volume in 1 second (FEV1). 3 The rate of onset, magnitude, and duration of the bronchodilator effect was dose related.

Similar articles

See all similar articles

Cited by 7 articles

See all "Cited by" articles

References

    1. Am Rev Respir Dis. 1977 Jan;115(1):57-65 - PubMed
    1. Thorax. 1976 Dec;31(6):720-3 - PubMed
    1. Arch Otolaryngol. 1972 Mar;95(3):248-51 - PubMed
    1. Thorax. 1975 Feb;30(1):80-5 - PubMed
    1. Am Rev Respir Dis. 1974 Apr;109(4):420-8 - PubMed

Publication types

LinkOut - more resources

Feedback